271 related articles for article (PubMed ID: 32454632)
1. The Role of Secondary Metabolites on Gynecologic Cancer Therapy: Some Pathways and Mechanisms.
Demirel MA; Süntar İ
Turk J Pharm Sci; 2017 Dec; 14(3):324-334. PubMed ID: 32454632
[TBL] [Abstract][Full Text] [Related]
2. The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action.
Garg P; Awasthi S; Horne D; Salgia R; Singhal SS
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188929. PubMed ID: 37286146
[TBL] [Abstract][Full Text] [Related]
3. Phytochemicals: a multitargeted approach to gynecologic cancer therapy.
Farrand L; Oh SW; Song YS; Tsang BK
Biomed Res Int; 2014; 2014():890141. PubMed ID: 25093186
[TBL] [Abstract][Full Text] [Related]
4. Secondary leukemia after chemotherapy and/or radiotherapy for gynecologic neoplasia.
Shimada T; Saito T; Okadome M; Shimamoto K; Ariyoshi K; Eto T; Tomita Y; Kodama K
Int J Gynecol Cancer; 2014 Feb; 24(2):178-83. PubMed ID: 24407580
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory Drugs and Herbs with Special Emphasis on Herbal Medicines for Countering Inflammatory Diseases and Disorders - A Review.
Yatoo MI; Gopalakrishnan A; Saxena A; Parray OR; Tufani NA; Chakraborty S; Tiwari R; Dhama K; Iqbal HMN
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):39-58. PubMed ID: 29336271
[TBL] [Abstract][Full Text] [Related]
6. Comparison between tumors in plants and human beings: Mechanisms of tumor development and therapy with secondary plant metabolites.
Ullrich CI; Aloni R; Saeed MEM; Ullrich W; Efferth T
Phytomedicine; 2019 Nov; 64():153081. PubMed ID: 31568956
[TBL] [Abstract][Full Text] [Related]
7. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on research in gynecologic oncology.
DeVita VT; Wasserman TH; Young RC; Carter SK
Cancer; 1976 Jul; 38(1 SUPPL):509-25. PubMed ID: 776390
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers.
Menderes G; Hicks C; Black JD; Schwab CL; Santin AD
Expert Opin Biol Ther; 2016 Aug; 16(8):989-1004. PubMed ID: 27070175
[TBL] [Abstract][Full Text] [Related]
10. The roles of pathology in targeted therapy of women with gynecologic cancers.
Murali R; Grisham RN; Soslow RA
Gynecol Oncol; 2018 Jan; 148(1):213-221. PubMed ID: 29174566
[TBL] [Abstract][Full Text] [Related]
11. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
12. Gynecologic cancers metastatic to the breast.
Moore DH; Wilson DK; Hurteau JA; Look KY; Stehman FB; Sutton GP
J Am Coll Surg; 1998 Aug; 187(2):178-81. PubMed ID: 9704965
[TBL] [Abstract][Full Text] [Related]
13. Phytochemicals in Anticancer Drug Development.
Dutt R; Garg V; Khatri N; Madan AK
Anticancer Agents Med Chem; 2019; 19(2):172-183. PubMed ID: 30398123
[TBL] [Abstract][Full Text] [Related]
14. Management of Vaginal Cancer.
Shrivastava SB; Agrawal G; Mittal M; Mishra P
Rev Recent Clin Trials; 2015; 10(4):289-97. PubMed ID: 26411952
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Care of the Survivor of Gynecologic Cancer: Managing the Menopause and Radiation Toxicity.
Van Le L; McCormack M
Am Soc Clin Oncol Educ Book; 2016; 35():e270-5. PubMed ID: 27249732
[TBL] [Abstract][Full Text] [Related]
16. Targeting IGF-1 signaling pathways in gynecologic malignancies.
Bruchim I; Werner H
Expert Opin Ther Targets; 2013 Mar; 17(3):307-20. PubMed ID: 23294364
[TBL] [Abstract][Full Text] [Related]
17. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
Salani R; Backes FJ; Fung MF; Holschneider CH; Parker LP; Bristow RE; Goff BA
Am J Obstet Gynecol; 2011 Jun; 204(6):466-78. PubMed ID: 21752752
[TBL] [Abstract][Full Text] [Related]
18. Potential Benefits of Edible Berries in the Management of Aerodigestive and Gastrointestinal Tract Cancers: Preclinical and Clinical Evidence.
Bishayee A; Haskell Y; Do C; Siveen KS; Mohandas N; Sethi G; Stoner GD
Crit Rev Food Sci Nutr; 2016 Jul; 56(10):1753-75. PubMed ID: 25781639
[TBL] [Abstract][Full Text] [Related]
19. Phytochemicals as Adjunctive with Conventional Anticancer Therapies.
Farzaei MH; Bahramsoltani R; Rahimi R
Curr Pharm Des; 2016; 22(27):4201-18. PubMed ID: 27262332
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer.
Zivanovic O; Khoury-Collado F; Abu-Rustum NR; Gemignani ML
Oncologist; 2009 Jul; 14(7):695-705. PubMed ID: 19608640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
